Neuronal localization of indoleamine 2,3-dioxygenase in mice

Neuroscience Letters

Volumn 387, Issue 2, 2005, Pages 95-99

  Roy, Edward J ^a   Takikawa, Osamu ^b   Kranz, David M ^a   Brown, Alicia R ^a   Thomas, Diana L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; QUINOLINIC ACID; TRYPTOPHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; HIPPOCAMPUS; IMMUNOREACTIVITY; INFLAMMATION; LYMPHOCYTE FUNCTION; MICROGLIA; MOUSE; NERVE CELL; NERVOUS SYSTEM; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ENCEPHALITIS; HIPPOCAMPUS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; KYNURENINE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICROGLIA; NERVE DEGENERATION; NEURONS; QUINOLINIC ACID; T-LYMPHOCYTES; TRYPTOPHAN; TRYPTOPHAN OXYGENASE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 23644450380     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.07.010     Document Type: Article

References (21)

1. F. Fallarino, U. Grohmann, C. Vacca, C. Orabona, A. Spreca, M.C. Fioretti, and P. Puccetti T cell apoptosis by kynurenines Adv. Exp. Med. Biol. 527 2003 183 190
2. M. Friberg, R. Jennings, M. Alsarraj, S. Dessureault, A. Cantor, M. Extermann, A.L. Mellor, D.H. Munn, and S.J. Antonia Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection Int. J. Cancer 101 2002 151 155
3. G.J. Guillemin, D.G. Smith, G.A. Smythe, P.J. Armati, and B.J. Brew Expression of the kynurenine pathway enzymes in human microglia and macrophages Adv. Exp. Med. Biol. 527 2003 105 112
4. G.J. Guillemin, G. Smythe, O. Takikawa, and B.J. Brew Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons Glia 49 2005 15 23
5. A.M. Hansen, H.J. Ball, A.J. Mitchell, J. Miu, O. Takikawa, and N.H. Hunt Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium Int. J. Parasitol. 34 2004 1309 1319
6. M.P. Heyes, C.L. Achim, C.A. Wiley, E.O. Major, K. Saito, and S.P. Markey Human microglia convert l-tryptophan into the neurotoxin quinolinic acid Biochem. J. 320 Pt 2 1996 595 597
7. M.P. Heyes, D. Rubinow, C. Lane, and S.P. Markey Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome Ann. Neurol. 26 1989 275 277
8. M.P. Heyes, K. Saito, J.S. Crowley, L.E. Davis, M.A. Demitrack, M. Der, L.A. Dilling, J. Elia, M.J. Kruesi, A. Lackner, S.A. Larsen, K. Lee, H.L. Leonard, S.P. Markey, A. Martin, S. Milstein, M.M. Mouradian, M.R. Pranzatelli, B.J. Quearrry, A. Salazar, M. Smith, S.E. Strauss, T. Sunderland, S.W. Swedo, and W.W. Tourtellotte Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease Brain 115 Pt 5 1992 1249 1273
9. M.P. Heyes, K. Saito, E.O. Major, S. Milstien, S.P. Markey, and J.H. Vickers A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from l-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate Brain 116 Pt 6 1993 1425 1450
10. H. Iwagaki, A. Hizuta, M. Uomoto, Y. Takeuchi, S. Saito, and N. Tanaka Cancer cachexia and depressive states: a neuro-endocrine-immunological disease? Acta Med. Okayama 51 1997 233 236
11. E. Kwidzinski, J. Bunse, A.D. Kovac, O. Ullrich, F. Zipp, R. Nitsch, and I. Bechmann IDO (indolamine 2,3-dioxygenase) expression and function in the CNS Adv. Exp. Med. Biol. 527 2003 113 118
12. J. Lestage, D. Verrier, K. Palin, and R. Dantzer The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen Brain Behav. Immun. 16 2002 596 601
13. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, and A.L. Mellor Inhibition of T cell proliferation by macrophage tryptophan catabolism J. Exp. Med. 189 1999 1363 1372
14. D.H. Munn, M.D. Sharma, D. Hou, B. Baban, J.R. Lee, S.J. Antonia, J.L. Messina, P. Chandler, P.A. Koni, and A.L. Mellor Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes J. Clin. Invest. 114 2004 280 290
15. D.H. Munn, M. Zhou, J.T. Attwood, I. Bondarev, S.J. Conway, B. Marshall, C. Brown, and A.L. Mellor Prevention of allogeneic fetal rejection by tryptophan catabolism Science 281 1998 1191 1193
16. K. Saito, S.P. Markey, and M.P. Heyes Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice Brain Res. 546 1991 151 154
17. A.M. Sardar, and G.P. Reynolds Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia Neurosci. Lett. 187 1995 9 12
18. R. Schwarcz, and R. Pellicciari Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities J. Pharmacol. Exp. Ther. 303 2002 1 10
19. S. Suzuki, S. Tone, O. Takikawa, T. Kubo, I. Kohno, and Y. Minatogawa Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepts Biochem. J. 355 2001 425 429
20. C. Uyttenhove, L. Pilotte, I. Theate, V. Stroobant, D. Colau, N. Parmentier, T. Boon, and B.J. Van den Eynde Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nat. Med. 9 2003 1269 1274
21. M.C. Wichers, and M. Maes The role of indoleamine 2, 3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression J. Psychiatry Neurosci. 29 2004 11 17